- Human Nutrition: 67% of the revenue. Grew by 23% during the quarter.
- Animal Nutrition: 11% of the revenue. Grew by 1% on YOY and de-grew by 23% on QOQ basis.
- Industrial Bio-Processing: 15% of revenue. Grew by 17% QOQ and 23% YOY. Food business grew by 26% YOY and Non-food business 6% YOY.
- Specialized manufacturing: 7% of revenue which grew by 50% YOY.
- Geographical areas including Europe & Asia (Ex-India) saw a slight de-growth.
- Building a new R&D center in Nasik, expected to be completed by December.
- Cash reserves will be used for potential acquisitions and dividends.
- Freight expenses and raw material prices have stabilized, with no significant impact expected in the future.
- Expects growth in the probiotics segment, but it is not factored into the current projections.
- The management expects growth in Q2 FY24 to remain flat and it will improve from Q3 FY24 onwards.
| Subscribe To Our Free Newsletter |
